Previous studies applying MLL-AF9 AML models confirmed that LSCs are enriched in c-Kit+Gr-1− (K+G−) or leukemic granulocyte–macrophage progenitor (L-GMP) populations. The gene discussed is MLLT3; the disease is acute myeloid leukemia.